SEC Tracker
Get the app

Immuneering IMRX

Immuneering appoints Grant C. Bogle to Board

Immuneering (IMRX) filed an 8-K with the SEC on Nov 9, 2026, 4:16 pm ET. Source: the filing on SEC EDGAR.

Item 5.02 Executive or director change

Form
8-K
Filed
Importance
Major
  1. Grant C. Bogle appointed as Class III Director
  2. Bogle will receive standard non-employee director compensation
  3. No committee assignments announced for Bogle

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Immuneering files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.